Skip Navigation

Nucleic Acids Research 2005 33(1):289-297; doi:10.1093/nar/gki170
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (1131K) Freely available
Right arrow Screen PDF (322K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Citing Articles
Right arrowScopus Links
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Zhou, T.
Right arrow Articles by Povirk, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, T.
Right arrow Articles by Povirk, L. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published online 12 January 2005

© 2005, the authors Nucleic Acids Research, Vol. 33 No. 1 © Oxford University Press 2005; all rights reserved
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use permissions, please contact journals.permissions{at}oupjournals.org.

Article

Deficiency in 3'-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1)

Tong Zhou, Jae Wan Lee, Haritha Tatavarthi, James R. Lupski2, Kristoffer Valerie1 and Lawrence F. Povirk*

Department of Pharmacology and Toxicology, Virginia Commonwealth University Richmond, VA 23298, USA 1 Department of Radiation Oncology, Virginia Commonwealth University Richmond, VA 23298, USA 2 Department of Molecular and Human Genetics, Baylor College of Medicine Houston, TX 77030, USA

*To whom correspondence should be addressed at Virginia Commonwealth University, PO Box 980230, Richmond, VA 23298-0230, USA. Tel: +1 804 828 9640; Fax: +1 804 828 8079; Email: lpovirk{at}mail2.vcu.edu

Received November 8, 2004. Revised December 16, 2004. Accepted December 16, 2004.

Tyrosyl-DNA phosphodiesterase (TDP1) is a DNA repair enzyme that removes peptide fragments linked through tyrosine to the 3' end of DNA, and can also remove 3'-phosphoglycolates (PGs) formed by free radical-mediated DNA cleavage. To assess whether TDP1 is primarily responsible for PG removal during in vitro end joining of DNA double-strand breaks (DSBs), whole-cell extracts were prepared from lymphoblastoid cells derived either from spinocerebellar ataxia with axonal neuropathy (SCAN1) patients, who have an inactivating mutation in the active site of TDP1, or from closely matched normal controls. Whereas extracts from normal cells catalyzed conversion of 3'-PG termini, both on single-strand oligomers and on 3' overhangs of DSBs, to 3'-phosphate termini, extracts of SCAN1 cells did not process either substrate. Addition of recombinant TDP1 to SCAN1 extracts restored 3'-PG removal, allowing subsequent gap filling on the aligned DSB ends. Two of three SCAN1 lines examined were slightly more radiosensitive than normal cells, but only for fractionated radiation in plateau phase. The results suggest that the TDP1 mutation in SCAN1 abolishes the 3'-PG processing activity of the enzyme, and that there are no other enzymes in cell extracts capable of processing protruding 3'-PG termini. However, the lack of severe radiosensitivity suggests that there must be alternative, TDP1-independent pathways for repair of 3'-PG DSBs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
C. Marchand, W. A. Lea, A. Jadhav, T. S. Dexheimer, C. P. Austin, J. Inglese, Y. Pommier, and A. Simeonov
Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay
Mol. Cancer Ther., January 1, 2009; 8(1): 240 - 248.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Gangloff, A. Murali, J. Xiong, C. J. Arnot, A. N. Weber, A. M. Sandercock, C. V. Robinson, R. Sarisky, A. Holzenburg, C. Kao, et al.
Structural Insight into the Mechanism of Activation of the Toll Receptor by the Dimeric Ligand Spatzle
J. Biol. Chem., May 23, 2008; 283(21): 14629 - 14635.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Antony, C. Marchand, A. G. Stephen, L. Thibaut, K. K. Agama, R. J. Fisher, and Y. Pommier
Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1
Nucleic Acids Res., July 26, 2007; 35(13): 4474 - 4484.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
T. Takahashi, M. Tada, S. Igarashi, A. Koyama, H. Date, A. Yokoseki, A. Shiga, Y. Yoshida, S. Tsuji, M. Nishizawa, et al.
Aprataxin, causative gene product for EAOH/AOA1, repairs DNA single-strand breaks with damaged 3'-phosphate and 3'-phosphoglycolate ends
Nucleic Acids Res., June 28, 2007; 35(11): 3797 - 3809.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. F. Povirk, T. Zhou, R. Zhou, M. J. Cowan, and S. M. Yannone
Processing of 3'-Phosphoglycolate-terminated DNA Double Strand Breaks by Artemis Nuclease
J. Biol. Chem., February 9, 2007; 282(6): 3547 - 3558.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
S. F. El-Khamisy and K. W. Caldecott
TDP1-dependent DNA single-strand break repair and neurodegeneration
Mutagenesis, July 1, 2006; 21(4): 219 - 224.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Z. Liao, L. Thibaut, A. Jobson, and Y. Pommier
Inhibition of Human Tyrosyl-DNA Phosphodiesterase by Aminoglycoside Antibiotics and Ribosome Inhibitors
Mol. Pharmacol., July 1, 2006; 70(1): 366 - 372.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. C. Nitiss, M. Malik, X. He, S. W. White, and J. L. Nitiss
Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage
PNAS, June 13, 2006; 103(24): 8953 - 8958.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Interthal, H. J. Chen, and J. J. Champoux
Human Tdp1 Cleaves a Broad Spectrum of Substrates, Including Phosphoamide Linkages
J. Biol. Chem., October 28, 2005; 280(43): 36518 - 36528.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.